Montes Archimedes Acquisition (ROIV)
(Delayed Data from NSDQ)
$11.88 USD
+0.20 (1.71%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $11.88 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.21 | -9.52% |
Earnings Summary
For their last quarter, Montes Archimedes Acquisition (ROIV) reported earnings of -$0.18 per share, beating the Zacks Consensus Estimate of $-0.21 per share. This reflects a positive earnings surprise of 14.29%. Look out for ROIV's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 19.23%.
Earnings History
Price & Consensus
Zacks News for ROIV
Axsome Therapeutics (AXSM) Reports Q2 Loss, Tops Revenue Estimates
ROIV: What are Zacks experts saying now?
Zacks Private Portfolio Services